Persistency of Mesenchymal Stromal/Stem Cells in Lungs.

BLI BM-MSCs MSCs MSCs tracking lung

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2021
Historique:
received: 13 05 2021
accepted: 17 06 2021
entrez: 2 8 2021
pubmed: 3 8 2021
medline: 3 8 2021
Statut: epublish

Résumé

Mesenchymal stromal/stem cells (MSCs) are a fibroblast-like cell population with high regenerative potential that can be isolated from many different tissues. Several data suggest MSCs as a therapeutic tool capable of migrating to a site of injury and guide tissue regeneration mainly through their secretome. Pulmonary first-pass effect occurs during intravenous administration of MSCs, where 50 to 80% of the cells tend to localize in the lungs. This phenomenon has been exploited to study MSC potential therapeutic effects in several preclinical models of lung diseases. Data demonstrated that, regardless of the lung disease severity and the delivery route, MSCs were not able to survive longer than 24 h in the respiratory tract but still surprisingly determined a therapeutic effect. In this work, two different mouse bone marrow-derived mesenchymal stromal/stem cell (mBM-MSC) lines, stably transduced with a third-generation lentiviral vector expressing luciferase and green fluorescent protein reporter genes tracking MSCs

Identifiants

pubmed: 34336863
doi: 10.3389/fcell.2021.709225
pmc: PMC8322774
doi:

Types de publication

Journal Article

Langues

eng

Pagination

709225

Informations de copyright

Copyright © 2021 Ferrini, Stellari, Franceschi, Macchi, Russo, Murgia, Grisendi, Villetti, Dominici and Donofrio.

Déclaration de conflit d'intérêts

EF, GV, and FS were employed by company Chiesi Farmaceutici S.p.A. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Stem Cells Transl Med. 2018 Jan;7(1):78-86
pubmed: 29210198
Clin Exp Immunol. 2010 Dec;162(3):474-86
pubmed: 20846162
Exp Hematol. 1976 Sep;4(5):267-74
pubmed: 976387
Am J Respir Crit Care Med. 2006 Jan 15;173(2):171-9
pubmed: 16179642
Sensors (Basel). 2011;11(1):180-206
pubmed: 22346573
J Thorac Dis. 2018 Sep;10(9):5607-5620
pubmed: 30416812
Adv Exp Med Biol. 2019;1084:187-206
pubmed: 31175638
Genes Dev. 2001 Jul 1;15(13):1593-612
pubmed: 11445534
J Immunol. 2007 Aug 1;179(3):1855-63
pubmed: 17641052
Cytotherapy. 2017 Jan;19(1):61-74
pubmed: 27836573
Am J Respir Cell Mol Biol. 2005 Oct;33(4):371-7
pubmed: 16037486
Haematologica. 2008 Oct;93(10):1457-65
pubmed: 18728032
Cell Transplant. 2010;19(2):219-30
pubmed: 19906330
Exp Hematol. 1974;2(2):83-92
pubmed: 4455512
Thorax. 2014 Sep;69(9):819-25
pubmed: 24891325
Cells. 2019 May 16;8(5):
pubmed: 31100966
Stem Cells. 2002;20(6):530-41
pubmed: 12456961
Stem Cells Transl Med. 2019 Sep;8(9):874-879
pubmed: 31091020
Sci Adv. 2021 Jun 9;7(24):
pubmed: 34108218
Mol Ther Methods Clin Dev. 2019 May 17;14:1-15
pubmed: 31236426
PLoS One. 2014 Apr 21;9(4):e95779
pubmed: 24752229
Respir Res. 2006 Dec 19;7:145
pubmed: 17177981
Circulation. 2003 Aug 19;108(7):863-8
pubmed: 12900340
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Stem Cells. 2020 Jun;38(6):797-807
pubmed: 32101344
PLoS One. 2014 Oct 20;9(10):e108974
pubmed: 25330334
Cells Tissues Organs. 2001;169(1):12-20
pubmed: 11340257
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L740-52
pubmed: 17616650
Lab Invest. 2014 Nov;94(11):1247-59
pubmed: 25199053
Cell Tissue Kinet. 1970 Oct;3(4):393-403
pubmed: 5523063
NPJ Regen Med. 2019 Dec 2;4:22
pubmed: 31815001
Stem Cell Res Ther. 2016 Jan 11;7:7
pubmed: 26753925
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30
pubmed: 19713447
J Clin Invest. 2009 Feb;119(2):336-48
pubmed: 19164856
Nature. 1988 Jul 28;334(6180):320-5
pubmed: 2839775
Circulation. 2005 Sep 6;112(10):1451-61
pubmed: 16129797
Front Immunol. 2012 Sep 26;3:297
pubmed: 23056000
Transgenic Res. 2011 Jun;20(3):481-9
pubmed: 20506040
Cell Rep. 2016 May 31;15(9):1901-9
pubmed: 27210752
Stem Cells Dev. 2009 Jun;18(5):683-92
pubmed: 19099374

Auteurs

Erica Ferrini (E)

Chiesi Farmaceutici S.p.A., Corporate Pre-Clinical R&D, Parma, Italy.
Department of Veterinary Science, University of Parma, Parma, Italy.

Fabio Franco Stellari (FF)

Chiesi Farmaceutici S.p.A., Corporate Pre-Clinical R&D, Parma, Italy.

Valentina Franceschi (V)

Department of Veterinary Science, University of Parma, Parma, Italy.

Francesca Macchi (F)

Department of Veterinary Science, University of Parma, Parma, Italy.

Luca Russo (L)

Department of Veterinary Science, University of Parma, Parma, Italy.

Alba Murgia (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Hospital of Modena, Modena, Italy.
Scientific and Technological Park of Medicine "Mario Veronesi," Mirandola, Italy.

Giulia Grisendi (G)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Hospital of Modena, Modena, Italy.

Gino Villetti (G)

Chiesi Farmaceutici S.p.A., Corporate Pre-Clinical R&D, Parma, Italy.

Massimo Dominici (M)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Hospital of Modena, Modena, Italy.
Scientific and Technological Park of Medicine "Mario Veronesi," Mirandola, Italy.

Gaetano Donofrio (G)

Department of Veterinary Science, University of Parma, Parma, Italy.

Classifications MeSH